A Study Evaluating the Effects of CLAG With Gleevec in Refractory or Relapsed Acute Myeloid Leukemia
Stopped Principal Investigator resigned position with the University of Cincinnati, closing study at this site will reopen study in new position
Conditions
- Chronic Myeloid Leukemia, Blast Crisis
- Acute Myeloid Leukemia
Interventions
- DRUG: Imatinib Mesylate
- DRUG: CLAG
Sponsor
University of Cincinnati
Collaborators